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Over the past decade, hypotheses regarding the site of Ir gene action have changed 
considerably (1, 2). The original, widely held concept  (3) that/r  genes were expressed 
in T  cells gave way to the belief that  they were expressed in antigen-presenting cells 
(APC) 1 of the macrophage-monocyte-dendritic cell lineage, or at the very least, in T 
cell-APC interactions. The B  cell, which actually produces the antibodies, was given 
a  relatively minor role. Some authors (4) presented evidence that the B cell played no 
role at all, that everything could be explained solely on the basis of T  cell interaction 
with the APC. Others  (5, 6)  presented evidence that the B  cell played a  role parallel 
to that of the APC in that T  cells were genetically restricted to interact with high but 
not  low  responder  B  cells as  well  as  APC.  This  controversy  was  at  least  partially 
resolved  by  the  discovery  (7,  8)  that  T  cell  help  for  Lyb5-  B  cells was  genetically 
restricted, whereas that for Lyb5  + B cells was not. These and related studies led to the 
hypothesis  that,  what  the  T  cell  saw  first  on  the  APC  (a  certain  combination  of 
antigen and Ia), it must see reproduced on the B cell to mediate help (9,  10). Most of 
these studies involved synthetic repeating polypeptide antigens, such as (T,G)-A--L. 
We  have  been  studying the  genetic control of the  immune  response to  a  natural 
globular protein antigen, sperm whale myoglobin (Mb), and have found that  the in 
viva antibody response (11), the in vitro T  cell response (12), and the in vitro antibody 
response (13) are all controlled by at least two/r genes mapping in distinct subregions, 
I-A  and I-C, of the H-2 complex. These genetically separable genes control responses 
to chemically distinct determinants on the same antigen molecule (12,  13). In the case 
of T  cell proliferation, we  found  that  the  selection of which  antigenic determinant 
was stimulatory for  (high  responder ×  low responder)F1 T  cells depended  on  the /r 
genes  of  the  strain  from  which  the  APC  were  obtained  (14).  Thus,  the  Ir  gene 
restriction of T  ceI1-APC interaction led to what had been described by Rosenthal et 
al.  (3)  as "determinant selection." 
However,  we  wished  to  explore  the  cellular  interactions  involved  in  regulating 
antibody production rather than T  cell proliferation. To do so, we recently developed 
(13) an in vitro culture system in which we can measure soluble Mb-specific antibody 
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secreted into the culture supernatant  fluid and can  determine its fine specificity for 
different  fragments  of myoglobin.  The  response  is  dependent  on  both  T  cells and 
APC. In~ the previous paper (15), we explored the role of the T  cell in this response by 
using neonatally tolerized mice  to  avoid allogeneic effects  (16).  We found  that  low 
responder mice, just like high responder mice, had helper T  cells that could cooperate 
with Fa or high responder B  cells and APC but not  low responder B  cells and APC. 
Because high and low responder T  cells could not be functionally distinguished, the 
present  study  was  carried  out  to  examine  the  role  of the  B  cell  and  APC  in  this 
response. In this study, the B  cells were specific for the antigen under Ir gene control, 
myoglobin, rather than for a  hapten, as in most of the earlier studies. Low responder 
B  cells were  found  to  be  competent  to  produce  anti-Mb  antibodies  but  unable  to 
receive help from  Mb-specific T  cells regardless of the source of APC.  (We have not 
been  able  to  demonstrate  a  similar  APC  restriction  in  this  secondary  response, 
although we cannot  prove that one does not exist.) Thus,  although  low responder T 
cells and B cells both appear competent to respond to Mb, the Ir gene defect expresses 
itself  in  the  interaction  between  the  two.  The  results  are  discussed  in  terms  of 
mechanisms for Ir gene action. 
Materials  and  Methods 
Animals.  B10.D2/nSn,  B10.BR/SgSn,  C57BL/10Sn  (also  denoted  B10),  (B10.BR  × 
B 10.D2)F1, and B6D2F1 mice were obtained from The Jackson Laboratories, Bar Harbor, ME. 
Mice were 8-16 wk of age at the first immunization. (B10 ×  B10.D2)F1 mice were bred by us. 
(CBA/N ×  DBA/2)F1 and  (DBA/2 ×  CBA/I~F1 mice were a  gift of Dr. John T. Kung and 
Dr. William E. Paul, National Institute of Allergy and Infectious Disease). 
Antigens.  Mb was obtained from the Accurate Chemical and Scientific Co., Hicksville, NY. 
The major chromatographic component, IV, purified as described previously (11),  was used 
throughout these studies. Fowl gamma globulin (chicken) (FTG)  from United States Biochem- 
ical Corp., Cleveland, Ohio, was used throughout these experiments. 
Preparation of Mb-coupled FyG  (Mb-FyG).  Preparation  of Mb-FyG was  performed by the 
method described by Schroer et al. (17). Our method of preparation of Mb-FyG was described 
in  detail  in  the  previous  paper  (15).  The  molar  substitution  of  Mb  to  FyG  was  1.5:1. 
Concentrations specified in the cultures are those of the FyG moiety. 
Immunization Schedule.  All mice were immunized intraperitoneally with  150/~g of purified 
Mb or with 200 #g of Mb-FyG in PBS emulsified 1:1  in complete Freund's adjuvant  (CFA) 
(H37Ra; Difco Laboratories, Detroit, MI) in total volume of 0.1 ml per animal. B6 -* B6D2F1 
(donor --~ recipient) chimeric mice were immunized intraperitoneally with  150 p.g of Mb in 
CFA and injected intravenously with 4 ×  107 hybrid F1 unirradiated APC (normal splenic glass 
adherent cells; SAC). 3 wk after immunization, the mice were boosted intraperitoneally with 
0.1 /~g of purified Mb or Mb-FyG in PBS, and they were killed by cervical dislocation 1-2 wk 
later. 
Cell Culture.  A culture system modified by that of Mishell-Dutton (18) was described in a 
previous paper (13).  Briefly, 2.5 ×  106 spleen cells from immunized mice were cultured with  1 
or 0.1  p~g/ml  of Mb  or 0.01  or 0.001  #g/ml  of Mb-FyG in  1.5  ml of RPMI  1640  medium 
supplemented with  10%  heat-inactivated fetal calf serum  (FCS)  (Microbiological Associates, 
Walkersville, MD),  100 U/ml penicillin, 100 #g/ml streptomycin, 2 mM L-glutamine, and 5 
×  10  -5 M 2-mercaptoethanol in flat bottomed wells (3524; Costar, Data Packaging, Cambridge, 
MA) for 10 d at 37°C, 6% CO2 on a  rocking plaiform. On the 4th d,  1 ml of supernatant was 
exchanged for fresh medium. On the  10th  d, culture supernatants were harvested to measure 
secreted antibody. 
Preparation of T  Cells.  T  cells were  prepared  by passage of spleen cells over  nylon-fiber 
column  and  collection of the  nylon-nonadherent eluate  (19).  Nonadherent  cell populations 
were irradiated with 250 rad from a  137Cs source to eliminate memory B cells. 1488  /r  GENE  FUNCTION IN T-B  INTERACTION 
Preparation of B Cells and Accessory Cells.  B cells and accessory cells were prepared by depleting 
splenic T  cells by pretreatment  with a rabbit  antibody against mouse brain-associated antigen 
(RaMB)  (Litton Bionetics, Kensington, MD) and guinea pig complement (Cedar Lane low-tox 
complement, Accurate Chemical and Scientific Corp.), as described  (13). 
Preparation of Splenic Glass Adherent Cells (SAC).  The  preparation  of SAC  was  described 
previously (13). 
Sephadex-GlO Passage.  Sephadex G 10 (Pharmacia Fine Chemicals, Div. of Pharmacia,  Inc., 
Piscataway,  N J)  passage of spleen cells performed by a  modification of the method described 
by Hodes et al.  (20)  was described previously (13,  15). 
Radioimmunoassayfor Antibodies to Mb.  The assay of antibody to Mb in the culture superna- 
tants was described elsewhere (13). 
Chimeras.  Recipient mice were irradiated  with 950 rad from an x-ray source and  reconsti- 
tuted 4-6 h later with  1-2 X  107 bone marrow cells that had been pretreated with RaMB and 
complement.  Chimeras  are  designated  as  bone  marrow  donor  ~  irradiated  recipient.  The 
animals used in this experiment were typed for H-2 using H-2-specific antisera (kindly supplied 
by  Dr.  David  Sachs,  National  Institutes  of Health,  Bethesda,  MD)  and  complement.  In  all 
animals tested results indicated that  splenocytes were of donor origin with no detectable cells 
of recipient haplotype by dye exclusion.  Dr.  Richard J.  Hodes and  Dr.  Pat  Dwyer, National 
Institutes of Health, generously provided these chimeric mice. 
Before use in culture, to remove any F1 cells that  might be present, derived either from the 
host or from the F~ SAC inoculum during immunization, spleen cells from chimeric mice were 
incubated  with  a  1:60  dilution  of anti-H-2 d antibodies  (4227:C57BL/10  anti-B10.D2,  titer 
1:128)  for 30 rain at 37°C. After another incubation with rabbit  complement  (Cedarlane low- 
tox  complement,  Accurate  Chemical  and  Scientific Corp.)  for  30  min  at  37°C,  cells  were 
extensively washed with RPMI  1640 supplemented with 5% FCS and were cultured with Mb. 
The antiserum used was a  generous gift of Dr. David H. Sachs, National Institutes of Health. 
Results 
Low  Responder  Mice  Immunized  with  Mb-FyG  Produced  Antibody  to  Mb.  To  study 
cellular  interactions  in  low  responder  mice,  we  first  had  to  ascertain  whether  low 
responder  B  ceils  could  produce  anti-Mb  under  any  circumstances.  When  low 
responder mice of haplotype H-2 b or H-2 k, were immunized  with Mb, they could not 
produce  antibody to Mb  in vivo (I 1) or in vitro (13).  However, if low responder mice 
were immunized  with  Mb-FyG,  their spleen  cells, cultured  with  Mb-FyG,  produced 
a  considerable  amount  of antibody  to  Mb  in  the  culture  supernatants  (Fig.  1).  To 
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Fro.  I.  Low responder  mice immunized with Mb-FyG showed a response to Mb. Spleen cells from 
mice immunized with Mb or Mb-FyG were cultured with Mb, 0.1 /~g/ml, or Mb-FyG, 0.01 ~tg/ml, 
respectively.  The antibody  concentrations  determined  by solid-phase  radioimmunoassay  are ex- 
pressed as mean +  SEM. D, cultured with Mb, 0.1 /~g/ml; II, cultured with Mb-FyG, 0.01 p.g/ml. YOICHI  KOHNO AND JAY  A.  BERZOFSKY 
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Fla. 2.  F-yG-primed  T cells can help Mb-primed B cells in the presence of Mg-FTG. Mb-primed 
B cells were prepared by depletion of T cells by pretreatment with RaMB and complement. FyG- 
primed T cells were prepared by passage of spleen cells over a nylon-fiber column and collection of 
nonadherent cells. Nonadherent cells were irradiated with 250 rad from 1~7Cs source to eliminate 
memory B ceils. Mb-primed B cells cocuhured with F'l,G-primed  T cells in the presence of Mb-FyG, 
0.01 #g/ml, or a mixture of Mb 0.1 #g/ml and FTG 0.01 #g/ml. The antibody concentrations are 
expressed as mean A cpm ± SEM, from a solid-phase radioimmunoassay,  r-q, cultured with Mb, 0.1 
#g/ml, assayed Ab to Mb; ~, cultured with Mb, 0.! #g, +  FyG, 0.01 #g/ml, assayed Ab to Mb; 
l,  cultured with Mb-F'yG, 0.01 btg/ml, assayed Ab to Mb; m, cultured with FyG, 0.01 #g/ml, 
assayed Ab to FyG. 
study the cellular mechanism of this responsiveness to Mb-F'~,  Mb-immunized high 
responder H-2  a or F1 B  cells were cultured with syngeneic F'yG-immunized T  cells. 
F-/G-immunized  T  cells help Mb-immunized B cells in the presence of Mb-FTG (Fig. 
2). However, when Mb-immunized B cells were cultured with FyG-immunized  T  cells 
in the presence of a  mixture of free Mb and free FTG, F'IK~-immunized  T  cells could 
not help Mb-immunized B cells (Fig. 2). Therefore, the covalent complex of Mb and 
FTG  is  necessary  to  obtain  this  carrier  effect.  In  the  case  of  the  low  responder, 
unseparated spleen cells immune to Mb-F'~  produced anti-Mb only when Mb-FTG 
was present in the culture, not when free Mb alone was present  (see control bars 2 
and 9 in Fig. 3). These data indicated that Mb-immunized  B cells in the low responder 
were  helped by F3K3-immunized T  cells but not  Mb-immunized T  cells.  Based  on 
these data, we conclude that clones of B cells specific for Mb exist in the low responder 
and that coupling Mb to a carrier such as FyG can overcome the barrier of the genetic 
control of responsiveness to Mb. 
The fine specificities of antibodies in the culture supernatants stimulated with Mb- 
FyG  were  studied,  and  low  responder  mice  immunized with  Mb-F'~3  produced 1490 
3o 
i  2¢ 
<  10 
/r GENE FUNCTION  IN T-B INTERACTION 
z  n- 
n 
Mb-F-/G* 
Spleen Cells  BIO.D2  BI0,BR  BIO,D2  BI0.BR  --  BI0.BR 
Treated  with  C'  '  C'  RaMB  ReMB  RaM8 
+C"  +C'  +C' 
,a¢ 
r-~ 
BIO,D2  B IO.BR 
RaMB  RaMB 
+C'  +C' 
BIO.BR  810.BR 
C'  RaMB 
+C" 
BIO.BR 
RaMB 
+C' 
Mb* 
(810.D2  x  BIO.SR)  --  --  --  +  +  +  +  -  - 
F I  T  Cells 
Added 
(B10.D2 x  810.BR)  ......  +  .... 
F I  APCs  20% 
Mb-F7 G* 
B10.BR  ........  +  + 
T  Ceils 
F]o.  3.  F1T cells help high responder B cells but not low responder B cells. B10.D2 and B10.BR 
mice were immunized with Mb-FyG. (B10.D2 X B10.BR) F1 mice were immunized with Mb. 
(B10.D2 x B10.BR)F1 T cells were cocultured with B10.D2 B cells or B10.BR B cells at the ratio of 
1:2 in the presence of Mb. (B10.D2 X B10.BR)F1 SAC were added to the culture of (B10.D2 X 
B 10.BR)F1 T cells and B  10.BR B cells in the presence  of Mb. As a control, Mb-FyG-primed B 10.BR 
B cells were cultured with syngeneic  Mb-FgG-primed B10.BR T cells in the presence of Mb-FyG. 
The antibody concentrations are expressed as mean ±  SEM. r-n, cultured with Mb,  1 /~g/ml; D, 
cultured with Mb-Fy(3,  0.01 /~g/ml. 
antibodies specific for both fragment (1-55) and fragment (132-153) (data not shown). 
However, we do not yet know whether or not the B cell precursor frequencies are the 
same in the high and low responder. 
(High Responder X  Low Responder)F1 Mb-immunieed  T Cells Help High Responder B Cells 
But  Not  Low  Responder B  Cells.  We  next  asked  whether  these  Mb-immune  low 
responder B cells could be activated by Mb-specific help rather than carrier (F'ld3)- 
specific help. Mb-immunized (B10.D2X B10.BR)F1 (H-2  d  ×  H-2 k) T  cells help Mb- 
FyG-immunized high  responder  B10.D2  B  cells  but  not  Mb-FgG-immunized low 
responder B 10.BR B cells (Fig. 3).  In control cultures, Mb-FyG-immunized B 10.BR 
spleen cells  produced  antibody to  Mb  in  the  presence of Mb-FyG, and  Mb-FgG- 
immunized B 10.BR B cells cultured with Mb-F'ld3-immunized  B 10.BR T  cells in the 
presence of Mb-FyG made antibody to Mb (Fig. 3). These control data indicated that 
B 10.BR B cells were competent and primed well with Mb. Thus, Mb-immunized F1 
helper T  cells collaborate with the high responder B10.D2 B cell and APC population 
but not the low responder B10.BR B cell and APC population. To know whether the 
failure of F]T  cells to help low responder B cells was due to the B cell itself or to a 
requirement for high responder APC, F1 APC were added to culture of F1 T  cells and YOICHI KOHNO  AND JAY  A.  BERZOFSKY  1491 
B10.BR B cells  at  the level of 20%  of the cultured cells  (Fig.  3).  Whereas the same 
number of FI APC could reconstitute the response of F1 spleen cells  depleted of APC 
by passage over Sephadex  G10  (Fig.  4),  addition  of F]  APC  did  not  enhance  the 
response of F1 T  cells  and B 10.BR B cells.  This experiment was repeated  at several 
ratios of F1 SAC to F1 T  cells  and B10.BR B cells,  and at no ratio was a  response by 
B10.BR B cells observed. From these results, we conclude that at least one manifes- 
tation  of the  Ir  gene  control  of the  response  to  Mb  is  an  inability  of otherwise 
competent low responder B cells to receive Mb-specific help from otherwise competent 
F1 T  cells. 
T  Cell-B  Cell  Ir  Gene  Restriction  in  a  Low  Responder  ~  (High  Responder  ×  Low 
Responder)Ft Bone Marrow Chimera.  The existence ofa T cell-B cell restriction resulting 
in low responsiveness was also demonstrated in bone marrow chimeras, in experiments 
in which the possibility of negative allogeneic effects due to residual T  cells in the low 
responder B cell population could be completely excluded. Chimeras were made by 
reconstituting lethally irradiated  (low responder ×  high responder)F1  B6D2F1  mice 
with  T-depleted  bone  marrow from  low responder  B6  mice.  Several  months  later, 
these mice were shown to have no detectable residual F] lymphoid cells  in the spleen, 
but only donor B6 cells  that had repopulated the mouse. A  number of groups have 
shown that  such low responder T  cells,  which  have matured  in  an  Ft  thymus, are 
tolerant to high responder alloantigens and can also cooperate with high responder B 
cells and APC in an antigen-specific response (2, 21). To be sure that Fa as well as low 
A 
"~  10 
t- 
e-- 
s 
t- 
e~ 
3 
40  B 
30 
20 
10 
lr 
B10.D2  x  B10.BR)F- 
_  G-10  G-10 
Passed  Passed 
N 
--  --  B6D2F, -- 
Treatment  of  Mb °  _  G-10  G  10  G-10 
F, Spleen  Cells  Passed  Passed  Passed 
Added  ~  (B10.D2  x  ~  _  --  B6D2F,  B10.D2 
APC  B10.BR)F 
FIG. 4.  Normal SAC reconstitute the lymphocyte response. APC were prepared by collection of 
SAC.  APC-depleted  cell  populations  were  prepared  by  passage  through  two  Sephadex  G-10 
columns. (B10.D2  ×  B10.BR)F] APC-depleted cells were reconstituted with SAC from (B10.D2  x 
B10.BR)FI and B6D2FI APC-depleted cells were reconstituted with SAC from B6D2F] or B10.D2. 
The antibody concentrations are expressed as mean +- SEM.  A, cultured  with Mb,  1 ~g/ml;  B, 
cultured with Mb, 0.1 #g/ml. 1492  Ir  GENE  FUNCTION  IN  T-B  INTERACTION 
responder APC were present in vivo, these mice were injected intravenously with 40 
X  I06  F1  SAC  at  the  time  of immunization.  If the  only  genetic  restriction  were 
between  T  cells  and  APC,  we  would  have  expected  the  chimeric  spleen  cells  so 
immunized to respond to Mb in culture. However, they did not respond, either alone 
or when  additional  high  responder  (B10.D2)  or F1  APC  were added  (Fig.  5).  Only 
when F1 B cells (as well as APC) were added was a response seen. Thus, the chimeric 
low responder B6 T  cells could provide Mb-specific help for B6D2F1 B cells, but they 
could not provide such help for syngeneic chimeric B6 B cells even in the presence of 
F1  APC.  Therefore,  genetic  restriction  in  the  Mb-specific interaction  between com- 
petent chimeric low responder T  cells and syngeneic low responder B cells resulted in 
nonresponsiveness. 
Failure to Demonstrate  Genetic Restriction  for  T  Cell-Antigen-presenting  Cell Interaction  in 
SecondaTy In  Vitro Response.  From the results of Fig.  3, we knew that there was an Ir 
genetic restriction in the interaction between T  cells and B cells, independent  of the 
source of antigen-presenting  cells.  However,  these  experiments  did  not  address  the 
question of whether there was also a  genetic restriction on the interaction between T 
cells  and  antigen-presenting  cells  in  the  same  cultures.  To  explore  this  issue,  we 
depleted Mb-immunized (high responder X low responder)F1 spleen cells of antigen- 
presenting  cells  by  two  sequential  passages  over  Sephadex  G10.  The  remaining 
population of Mb-primed T  cells and B cells did not secrete anti-Mb  in response to 
soluble Mb in the culture in the absence of added APC (Fig. 6). When these cultures 
were reconstituted with splenic glass-adherent cells (SAC) that had been pulsed with 
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FIG.  5.  (B6 --~ B6D2F1)  chimeric cells can help  B6D2F1  B  cells.  (B6 ~  B6D2F1)  chimera spleen 
cells from chimeras immunized with Mb in the presence of F1 SAC were cocultured with SAC from 
B6D2FI,  BI0.D2, or C57BL/10  in  the presence of Mb.  (B6 --* B6D2F1)  chimera spleen cells were 
also cultured with B6D2E]  B cells at the ratio of 1 : 1. The antibody concentrations are expressed as 
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FIo.  6.  Low responder APC reconstitute the response of F1 lymphocytes in an in vitro secondary 
antibody response. Mb-immune (B10.D2  ×  B10.BR)F]  (high responder X low responder)Fl spleen 
cells were depleted of APC by two sequential passages over columns of Sephadex G10. These were 
then cultured either alone with 0.1  /Lg/ml Mb or without soluble Mb in the presence of 20%  as 
many parental high or low responder SAC that had been precuhured overnight with 10/~g/ml Mb 
and then extensively washed to remove free Mb. The specific anti-Mb antibody concentration in 
the culture supernatant after 10 d of culture is expressed as mean +  SEM. r-n, cultured with Mb, 0.1 
/Lg/ml; •,  cultured without soluble Mb. 
antigen by preincubation overnight with  10/~g/ml Mb, either high responder or low 
responder SAC restored the response-(Fig. 6). The same was true when unpulsed SAC 
and soluble Mb were used in the culture, but even under the most stringent condition 
of pulsed low responder SAC and no soluble Mb, no genetic restriction at this level 
could be demonstrated (Fig. 6). It is difficult to deplete spleen cells of APC sufficiently 
to prevent an in vitro secondary response without also depleting B cells.  Because we 
were able to deplete sufficiently to prevent any response to soluble antigen without 
added  APC,  the  depletion  must  have  been  rather  stringent.  Nevertheless,  it  is 
impossible to be sure that every F1 APC was removed. Therefore, we cannot conclude 
that  no genetic restriction  exists  for any APC function  in  this  secondary response, 
only that it is very difficult to demonstrate one. In contrast, the ease of demonstrating 
an  Ir  genetic  restriction  on  T  cell-B  cell  interaction  leads  us  to  conclude that  the 
major manifestation of Ir gene control during these secondary responses in cultures is 
a genetic restriction on T  cell-B cell, not T  celI-APC interaction. 
Lyb-5-  B  Cells  Participate  in  the Response  to Mb.  CBA/N mice and  F1  male mice, 
which are hemizygous for the CBA/N X  chromosome, carryed an X-linked recessive 
defect that is reflected in part  in an absence of a  subclass of mature B cells  (22).  B 
cells  can  be  separated  into  two  subpopulations  based  on  their  expression  of the 
differentiation  antigen,  Lyb-5. B cells  expressing the  Lyb-5 determinant  are a  late- 
appearing  subpopulation  in  normal  mice  and  are  absent  in  mutant  CBA/N mice 
(22).  Recently, the requirement was demonstrated (7, 8) for T  helper cell recognition 1494  b  GENE  FUNCTION  IN  T-B  INTERACTION 
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Fro.  7.  Lyb-5- B cells can participate in the response to Mb. Spleen cells  from B10.D2,  BI0.BR, 
(CBA/N X  DBA/2)F1  male  (Lyb-5-)  or  (DBA/2  X CBA/N)Fa  male  (Lyb-5- and  Lyb-5  +)  mice 
immunized with Mb were cultured with Mb 0.1/~g,/ml.  The antibody concentrations are expressed 
as mean +  SEM. 
of the MHC determinants expressed on B cells for activation of the Lyb-5-negative B 
cell  subpopulation but not for activation of the Lyb-5-positive B cell subpopulation 
in the primary response and secondary response to TNP-KLH. In view of the MHC 
genetic  restriction  in  T-B cell  interaction  that  we just  demonstrated  to  be  at  least 
partially responsible for the Ir gene control of the response to Mb, we examined the 
possible  participation  of Lyb-5-negative B  cells  in  the  tertiary  in  vitro  antibody 
response to Mb. To do so, we compared the response of spleen cells  from (CBA/N X 
DBA/2)F1 male  mice containing only Lyb-5- B cells  with  that  of spleen cells  from 
reciprocal  (DBA/2  x  CBA/N)F1 male  mice containing both  Lyb-5  + and  Lyb-5- B 
cells.  (CBA/N  X  DBA/2)F~  male  mice  produced  the  same  amount  of antibodies 
specific for Mb as  (DBA/2 X CBA/N)F1 or high responder B10.D2 mice and much 
higher than  low responder B10.BR mice  (Fig.  7). These observations indicated that 
the Lyb-5-negative B cell subpopulation can participate  in the response to Mb and 
probably  constitutes  a  major  portion  of the  response  because  no  increment  was 
observed when both subpopulations were present. 
Discussion 
In this communication, we attempted to elucidate the role of cellular interactions 
in regulating the immune response to Mb. To study the interaction between T  cells 
and B cells,  helper T  cells  from F1 hybrid mice and B cells  from parental mice were 
cocultured. The primary observation was that  F1 T  cells  cooperated only with high 
responder,  not  with  low responder,  B  cells,  even  when  both  populations of B  cells YOICHI KOHNO AND JAY A.  BERZOFSKY  1495 
were competent to produce anti-Mb with appropriate help, and even in the presence 
of adequate F1 APC. This result was also observed in chimeras and may be correlated 
with  the  function  of Lyb-5-negative B  cells  demonstrated  in  this  response.  It  was 
difficult to demonstrate any similar restriction on the interaction between T  cells and 
APC in this secondary response. 
In this in vitro tertiary response, both T  cells and B cells must be primed in vivo 
(13). Therefore, we had to be certain whether B cells from low responders were primed 
well  with  Mb  in  vivo or  not.  Mb-coupled  FyG was  used  to  prime  B  cells  in  low 
responder mice by taking advantage of the carrier effect provided by FyG (23-25). 
The results indicated that clones of B cells specific for Mb exist in low responder mice, 
and these B cells can be primed in vivo and induced  to secrete anti-Mb in vitro by 
taking advantage of carrier  (F3,G)-specific helper T  cells,  even though  they  do not 
function  with  syngeneic or  F1  Mb-specific T  cells.  (The  function  of helper  T  cells 
specific for Mb in low responder strains was examined in the previous paper [15].) 
We do not believe that the failure of Mb-specific Fa T  cells to help low responder 
B cells is due to a negative allogeneic effect (26)  or to the existence of suppressor cells 
in  the  B  cell  population  in  low  responder  mice.  Although  the  B  cells used  in  our 
studies appeared to be adequately depleted of T  cells, to rule out these possibilities, 
low responder B cells were cultured with unseparated F1 spleen cells. Any suppressive 
effect  by  low  responder  B  cells  or  by  residual  T  cells  contaminating  the  B  cell 
population could not be observed (15).  Also, the same results were obtained with B 
cells from tolerant B6 ~  B6D2Fx chimeras. Therefore, there is no evidence to suggest 
that suppression in the low responder B cell preparation is responsible for the failure 
of help  by F1  helper T  cells  for low  responder  B  cells.  We have not  excluded  the 
possibility of a  haplotype-specific T  suppressor cell in  the F1 T  cell population  that 
suppresses the response of low but not high responder B cells and APC, as has been 
observed  in  the  response to  the  terpolymer of glutamic  acid  6°-alanine3°-tyrosinel° 
(GAT) (27).  However, in contrast to the GAT system, we could not detect suppression 
by Mb-primed low responder spleen cells of the response of syngeneic Mb-FyG-primed 
spleen cells to Mb-F),G in culture  (H. Kawamura and J.  A. Berzofsky, unpublished 
observation). Therefore, there is no reason to suspect such suppression is responsible 
for the genetic restriction observed. 
Our experiments complement those of several previous studies  (5,  6, 28)  in which 
B cells were primed with the hapten tri- or dinitrophenyl (TNP or DNP) to which the 
response  is  not  genetically  controlled,  and  T  cells  were  primed  with  a  synthetic 
polypeptide carrier to which the response is controlled by the relevant Ir genes. In the 
current study, B cells were primed with Mb, to which the response is controlled by Ir 
genes, and T  cells were primed with  either Mb or the  immunogeneic carrier FyG. 
Therefore, if Ir genes functioned  in  B  cells, we could expect to detect  their activity 
more readily. The current  study extends these earlier results  (5,  6,  28)  to show that 
low responder B cells specific for the antigen under Ir gene control can be primed in 
vivo and  can  be  stimulated  to  secrete  anti-Mb  when  helped  by syngeneic  carrier 
(FyG)-specific T  cells.  However,  they  are  not  helped  by Mb-specific T  cells  (from 
either syngeneic or F1 hybrid mice). Either this result could be due to the failure of 
Mb-specific B cells to receive help from Mb-specific T  cells, or it could be due to a 
failure  to  prime helper  T  cells  specific  for Mb  in  the  context  of low  responder  Ia 
antigens. Comparing our results with the earlier results using hapten-specific B cells 1496  Ir GENE FUNCTION IN T-B INTERACTION 
that should not be directly affected by the Ir gene function, we might conclude that 
this  phenomenon  is  independent  of B  cell  specificity,  and,  thus,  that  the  latter 
explanation  seems  more  likely.  However,  given  our  observation  of T  cell-B  cell 
restriction in the absence of demonstrable T  celI-APC restriction, we must emphasize 
that  this T  cell-B cell  genetic restriction  may be a  fundamental Ir restriction  in  its 
own right, not just a  mirror of T  cell  priming. Thus, whether the B cells  are specific 
for the antigen under Ir gene control or for a hapten attached to that antigen, B cells 
bearing only low responder Ia antigens may be unable to receive help  from T  cells 
specific for the antigen under Ir gene control. The latter explanation, however, is still 
subject to two interpretations: either the T  cells  that would be specific for Mb in the 
context of low responder Ia are missing from the repertoire,  or they are potentially 
present but cannot interact with antigen on low responder APC or B cells because of 
a  defect  in  antigen  presentation  by the  low responder Ia. This  latter  dichotomy of 
interpretations remains unresolved. 
In  a  response  not  controlled  by  Ir  genes,  Sprent  (29) reported  that  F1  T  cells 
activated in mice of one parental  strain collaborated well with  B cells  of this strain 
but poorly with B cells  of the opposite strain.  On the other hand, Singer et al.  (30) 
showed that each parent-specific F1 T  cell subpopulation was triggered only by one 
parent's  accessory cells  (APC);  but  once  triggered,  each  parent-specific  F1  T  cell 
subpopulation was capable of activating either parent's B cells  in vitro in a  primary 
anti-hapten  PFC  response  to TNP-keyhole limpet  hemocyanin  (KLH).  The  latter 
results  suggested  that  there  exists  a  genetic  restriction  in  the  cellular  interaction 
between T  cells  and APC, not between T  cells  and B cells.  One explanation for the 
apprent  discrepancy regarding the  requirement  for T  cells  to  recognize the  MHC 
determinants expressed on B cells rather than just on APC was proposed by Singer et 
al.  (7)  and Asano et  al.  (8). These  investigators showed that  ontogenically distinct 
subpopulations  of B  cells  have  distinct  cellular  activation  requirements  and  that 
activation by helper T  cells  of Lyb-5- B cells  is MHC restricted,  whereas activation 
of Lyb-5  + B cells is not genetically restricted in the primary or secondary response to 
TNP-KLH in vitro. A different, but in some ways analogous, result was reported by 
Andersson et al.  (31),  namely, that small resting B cells  required  MHC-restricted T 
cell  help, whereas B cell blasts could respond to less specific signals. Thus, one may 
conclude in general that the type of B cell participating in the response may determine 
whether one observes genetic restrictions in T-B interactions or not. 
To  test  for the  participation  of Lyb-5- B  cells  in  the  Ir-gene controlled  in  vitro 
response to Mb under the conditions we use, we took advantage of the CBA/N X- 
linked genetic trait that results in the absence of Lyb-5  + B cells  in these mice or the 
male progeny of CBA/N mothers.  Spleen cells  from  (CBA/N~? X  DBA/2c~)F1  male 
mice, containing only Lyb-5- B cells, showed just as high a response to Mb as spleen 
cells from phenotypically normal reciprocal (DBA/22 ×  CBA/Nc~)F1 male mice (i.e., 
from  DBA/2  mothers)  containing  both  Lyb-5-  and  Lyb-5  +  B  cells.  This  result 
indicated  that  Lyb-5- B  cells  also  participated  in  the  response  to  Mb  under  our 
conditions of immunization and culture, and the genetic restriction between T  cells 
and B cells  reported in this communication is reasonably assumed to be due to the 
participation of Lyb-5- B cells.  Therefore, these data demonstrate,  in  analogy with 
the results for genetic restriction in responses not under Ir gene control (7, 8), that Ir 
gene  defects  are  manifested  in  T  cell-B  cell  as  well  as  T  cell-APC  interactions  in YOICHI  KOHNO AND JAY  A.  BERZOFSKY  1497 
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Fro. 8.  Genetic restriction in the cellular interaction between T and B lymphocytes: a site of/r 
gene action. Competent Mb-specific  helper T cells in low responder mice (tolerant to high responder 
H-2 and Ia antigens) were demonstrated by their ability to help high responder Mb-specific  B cells 
(15). Competent Mb-specific B cells in the low responder were demonstrated by their ability to 
make anti-Mb in the presence of carrier  (FyG)-specific syngeneic helper T  cells and Mb-FyG. 
However, a manifestation of the Ir gene defect is a failure of the competent low responder Mb- 
specific B cells to be helped by Mb-specifie  T cells. See text for details. 
responses in which Lyb-5- B cells are the major participants. 
It should be noted that we,  like Yamashita and Shevach  (6), could not detect  T 
celI-APC restriction in the  in vitro culture, even though  both we  and they readily 
detected T-B restriction. When we tested F1 T  cells and B cells (depleted of APC by 
two  passages  over  Sephadex  G10)  and  splenic  adherent  cells  derived  from  high 
responder or low responder mice, low responder APC  reconstituted the response as 
well as did high responder APC (Fig. 6). In both their case and ours, residual F1 APC 
are very difficult to exclude, so it is impossible to say that there was no restriction for 
antigen presentation by adherent cells in the in vitro secondary response, only that we 
could not detect it as readily as we could detect T  cell-B cell restriction. Nevertheless, 
neither of these results excludes the possibility that such T  cell-APC genetic restriction 
is critical during antigen priming in vivo and, therefore, accounts for the failure to 
prime helper T  cells restricted to interact with the low responder B cells. In fact, one 
interpretation of our results is that a  T  celI-APC genetically restricted interaction is 
essential during in vivo priming, at  which  time T  cells specific for  antigen in the 
context of high responder Ia proliferate. Having once proliferated as much as necessary 
during in vivo priming and boosting, these helper T  cells may no longer require a 
genetically restricted interaction with APC in the in vitro tertiary response,  2 so that 
the only genetically restricted interaction required in the culture is between T  cells 
and B  cells. This T-B restriction may mirror the T-APC restriction during priming 
(9,  10)  but, also, it may be viewed as a  fundamental restriction of equal importance 
to that during priming. 
Our findings are summarized schematically in Fig. 8.  In the previous paper  (15), 
we showed  that  low responder mice can produce competent, Mb-specific helper T 
2  The possibility that  the helper T cells need no longer proliferate to function in the in vitro tertiary 
response is supported by the observation that their activity in vitro is resistant to low-dose irradiation (250- 
500 rad), although this dose might not be sufficient to prevent all proliferation of helper T cells, even 
though it does prevent proliferation and secretion by B cells. 1498  Ir GENE  FUNCTION IN T-B  INTERACTION 
cells, but only ones competent to interact  with high responder or F1 B cells and APC. 
In the  present  paper,  we  found  that  low responder  mice have  B  cells  competent  to 
produce  anti-Mb  antibodies  when  they  receive  the  appropriate  help.  However,  the 
help must be specific for a carrier such as FyG, not for Mb itself. Thus, although both 
the helper T  cell compartment and the B cell compartment in the low responder have 
functional  Mb-specific  cells,  the  low  responder  or  even  (high  responder  ×  low 
responder)F1  Mb-specific  T  cells  cannot  help  low  responder  Mb-specific  B  cells, 
regardless of the source of APC. It is in  this T  cell-B cell interaction  that  the Ir gene 
"defect"  lies,  at  least  at  the  effector stage  of the  response.  Of course,  a  defect  in  a 
cellular interaction  must reflect  the properties  of one or both cells involved.  Because 
the low responder B cells are competent  to make anti-Mb  and because similar results 
have been found for hapten-specific B cells (see above), it seems likely that the failure 
to  interact  reflects  the  specificity  of the  helper  T  cell.  The  competence  of the  low 
responder Mb-specific T  cells is for helping high responder B cells, not low responder 
B cells. As noted above, this specificity may be imposed at the time of in vivo priming, 
but  ultimately  may be  due  either  to  an  absence  from  the  T  cell  repertoire  of cells 
capable of recognizing Mb in association with low responder Ia antigens or to a defect 
in some molecular interaction between Mb and low responder Ia on the APC and/or 
on the B cell itself. In the latter case, especially in view of the failure of low responder 
B cells to receiw: help  from high responder,  low responder,  or F1 Mb-specific T  cells 
(this  report  and  ref.  15),  the/r  gene defect  behaves  operationally  as a  B  cell  defect. 
This last  dilemma is the subject of current  investigation. 
Finally,  we suggest  that  if this  Ir gene phenomenon  is  a  fundamental  property of 
the Ia on the B cell in the same way that  it involves the Ia on the APC (9), the B cell 
should be able to mediate determination  selection in the same way the APC has been 
shown to do in the case ofT  cell proliferative responses  (3,  14).  That is, the Ia on the 
B cell should limit the epitope fine specificity of antigen-specific T  cells that can help 
that  B cell. We are currently testing that hypothesis. 
Summary 
We studied  the genetic restrictions  on the interaction  between T  cells,  B cells, and 
antigen-presenting  cells  (APC)  involved  in  the H-2-1inked  Ir  gene  control  of the  in 
vitro secondary  antibody response  to sperm  whale  myoglobin  (Mb)  in  mice. The  B 
cells in this study were specific for Mb itself, rather than for a  hapten unrelated to the 
/r gene control, as in many previous studies.  Low responder mice immunized  in vivo 
with Mb bound to an immunogenic carrier, fowl gamma globulin  (FyG), produced B 
cells competent to secrete anti-Mb  antibodies  in vitro if they received FyG-specific T 
cell  help.  However,  (high-responder  X  low  responder)F1  T  cells  from  Mb-immune 
mice did not help these primed low responder  (H-2 k or H-2 b) B cells in vitro, even in 
the presence of various numbers of F1 APC that were demonstrated  to be competent 
to  reconstitute  the  response  of spleen  cells  depleted  of APC.  Similar  results  were 
obtained  with  B6  ---*  B6D2FI  radiation  bone  marrow  chimeras.  Genotypic  low 
responder (H-2  b) T  cells from these mice helped Mb-primed B61)2F1 B cells plus APC, 
but did not help syngeneic chimeric H-2 b B cells, even in the presence of F1 APC. In 
contrast, we could not detect any Ir restriction on APC function during these in vitro 
secondary responses.  Moveover, in the preceding paper, we found that low responder 
mice neonatally tolerized to high responder H-2 had competent  Mb-specific helper T YOICHI  KOHNO  AND JAY  A. BERZOFSKY  1499 
cells  capable  of helping  high  responder  but  not  low  responder  B  cells  and  APC. 
Therefore,  although  functional  Mb-specific T  cells  and  B  cells  both  exist  in  low 
responder  mice,  the  Ir  gene  defect  is  a  manifestation  of the  failure  of syngeneic 
collaboration between these two cell types. This genetic restriction on the interaction 
between T  cells and B  cells is consistent with the additional new finding that Lyb-5- 
negative B cells are a  major participant in this in vitro secondary response because it 
is  this  Lyb-5-negative subpopulation  of B  cells  that  have  recently  been  shown  to 
require  genetically  restricted  help.  The  Ir  gene  defect  behaves  operationally as  a 
failure of low responder B cells to receive help from any source of Mb-specific T  cells, 
either high  responder,  low responder,  or F1.  The  possible additional role of T  cell- 
APC  interactions, either during primary immunization  in  vivo or in  the secondary 
culture, is discussed. 
The authors thank Dr.  Ira Berkower, Dr.  Richard Hodes, and Dr. Alfred Singer for helpful 
discussion, Dr. Richard Hodes and Dr. Pat Dwyer for gifts of bone marrow chimeras, Dr. John 
T. Kung and Dr. William E. Paul for gifts of (CBA/N ×  DBA/2)F1 and (DBA/2 ×  CBA/N)FI 
mice, and Dr. Richard Hodes, Dr. Alfred Singer, and Dr. David H. Sachs for critical review of 
the manuscript. We are grateful to Ms. Carla Replogle and Mr. Christopher Cox for assistance 
in the preparation of the manuscript. 
Received  for publication 3 May 1982 and in revised  form 2 August 1982. 
References 
1.  Benacerraf,  B.,  and  R.  N.  Germain.  1978. The  immune  response  genes  of the  major 
histocompatibility complex. Immunol. Rev. 38:71. 
2.  Berzofsky, J. A. 1980. Immune response genes in the regulation of mammalian immunity. 
In Biological Regulation and Development. R. F. Goldberger, editor. Plenum Press, New 
York. II:467. 
3.  Rosenthal, A. S.  1978. Determinant selection and macrophage function in genetic control 
of the immune response. Immunol. Rev. 40:136. 
4.  Singer, A., K. S. Hathcock, and R. J. Hodes. 1979. Cellular and genetic control of antibody 
responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B 
cells..]. Exp. Med. 149:1208. 
5.  Kappler, J.  W.,  and  P.  Marrack.  1977. The  role of H-2-1inked  genes  in  helper T-cell 
function. I. In vitro expression in B cells of immune response genes controlling helper T-cell 
activity. J. Exp. Med. 146:1748. 
6.  Yamashita, U., and  E.  M.  Shevach.  1978. The histocompatibility restrictions on macro- 
phage T-helper cell interaction determine the histocompatibility restrictions on T-helper 
cell B-cell interaction. J. Exp. Med. 148:1171. 
7.  Singer, A., P. J.  Morrissey, K. S.  Hathcock, A. Ahmed, I. Scher, and R. J.  Hodes.  1981. 
Role of the major histocompatibility complex in T  cell activation of B cell subpopulations. 
Lyb-5  + and Lyb-5- B cell subpopulations differ in their requirement for major histocom- 
patibility complex-restricted T  cell recognition.J. Exp. Med. 154:501. 
8.  Asano, Y., A. Singer, and R. J. Hodes. 1981. Role of the major histocompatibility complex 
in T  cell activation of B cell subpopulations. Major histocompatibility complex-restricted 
and -unrestricted B cell responses are mediated by distinct B cell subpopulations. J.  Exp. 
Med. 154:1100. 
9.  Benacerraf, B. 1978. A hypothesis to relate the specificity ofT lymphocytes and the activity 
of I region-specific Ir genes in macrophages and B lymphocytes. J. Immunol. 120:1809. 
10.  Paul, W. E., and B. Benacerraf. 1977. Functional specificity of thymus-dependent lympho- 1500  Ir GENE FUNCTION  IN T-B INTERACTION 
cytes. Science (Wash. D.  C.).  195:1293. 
11.  Berzofsky, J. A.  1978. Genetic control of the immune response to mammalian myoglobin 
in mice. I. More than one/-region gene in H-2 controls the antibody response.J. Immunol. 
120:360. 
12.  Berzofsky, J.  A.,  L.  K.  Richman, and D. J.  Killion.  1979. Distinct H-2-1inked  Ir  genes 
control both antibody and T cell responses  to different determinants on the same antigen, 
myoglobin. Proc. Natl.  Acad. Sci. U. S. A. 76:4046. 
13.  Kohno, Y., andJ. A. Berzofsky. 1982. Genetic control of the immune response to myoglobin. 
V. Antibody production in vitro is macrophage and T cell dependent and is under control 
of two determinant-specific Ir genes. J. Immunol.  128:2458. 
14.  Richman, L.  K., W. Strober, and J.  A. Berzofsky.  1980. Genetic control of the immune 
response to myoglobin. III. Determinant-specific,  two Ir gene phenotype is regulated by the 
genotype of reconstituting Kupffer cells.J. Immunol.  124:619. 
15.  Kohno, Y., andJ. A. Berzofsky. 1982. Genetic control of the immune response to myoglobin. 
Both low and high responder T  cells tolerant to the other MHC help high but not low 
responder B cells.J. Exp. Med.  156:791. 
16.  Streilein, J.  W.  1979. Neonatal tolerance: towards  an immunogenetic definition of self. 
Immunol. Rev. 46:125. 
17.  Schroer, J. A., J. K. Inman, J. W. Thomas, and A. S. Rosenthal. 1979. H-2-1inked Ir gene 
control  of  antibody responses  to  insulin. I.  Anti-insulin plaque-forming cell  primary 
responses.J. Immunol. 123:670. 
18.  Mishell, R. I., and R. W. Dutton.  1967. Immunization of dissociated spleen cell cultures 
from normal mice.J. Exp. Med.  126:423. 
19.  Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation 
of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645. 
20.  Hodes, R. J., G. B. Ahmann, K. S. Hathcock, H. B. Dickler, and A. Singer. 1978. Cellular 
and genetic control of antibody responses in vitro. IV. Expression of Ia antigens on accessory 
cells required for responses  to soluble antigens including a response under Ir gene control. 
J. Immunol. 121:1501. 
21.  Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on 
the biological role of polymorphic major transplantion antigens determining T-cell restric- 
tion-specificity, function, and responsiveness.  Adv. Immunol. 27:51. 
22.  Ahmed, A., I. Scher, S. O. Sharrow, A. H. Smith, W. E. Paul, D. H. Sachs, and K. W. Sell. 
1977. B-lymphocyte heterogeneity: development and characterization of an alloantiserum 
which distinguishes B-lymphocyte differentiation alloantigens.J. Exp. Med.  145:101. 
23.  Green, I.,  W.  E.  Paul,  and  B.  Benacerraf.  1966. The behavior of hapten-poly-e-lysine 
conjugates as  complete antigens in genetic responder and as  haptens  in nonresponder 
guinea pigs.J. Exp. Med.  123:859. 
24.  McDevitt,  H.  O.  1968. Genetic control of the  antibody response.  III.  Qualitative and 
quantitative characterization of the  antibody response to  (T,G)-A--L in CBA and C57 
mice. J. Immunol.  100:485. 
25.  Kapp, J. A., C. W. Pierce,  and B. Benacerraf.  1973. Genetic control of immune responses 
in vitro.  II.  Cellular requirements for  the  development of primary plaque-forming cell 
responses  to  the random terpolymer e-glutamic acid6°-L-alanine3°-c-tyrosine 1° (GAT) by 
mouse spleen cells in vitro. J. Exp. Med.  138:1121. 
26.  Swain, S. L., and R. W. Dutton. 1977. Negative allogeneic effects in vitro. I. Allogeneic T 
cells markedly suppress the secondary antibody-forming  cell response.]'. Irnmunol. 118:2262. 
27.  Pierce, C. W., andJ. A. Kapp. 1978. Suppressor T-cell activity in responder x  nonresponder 
(C57BL/10 ×  DBA/1)FI spleen cells responsive to L-Glutamic acid6°-L-Alanine3°-L-Tyro - 
sinel°.J. Exp. Med.  148:1282. 
28.  Katz,  D.  H.,  T.  Hamaoka,  M.  E.  Dorf,  P.  H.  Maurer,  and  B.  Benacerraf.  1973. Cell YOICHI  KOHNO  AND JAY  A. BERZOFSKY  1501 
interactions between  histoincompatible T  and  B  lymphocytes. IV.  Involvement  of the 
immune response (It) gene in the control of lymphocyte interactions in responses controlled 
by the gene.J. Exp. Med. 138:734. 
29.  Sprent, J.  1978. Restricted  helper  function  of F1  hybrid T  cells positively selected to 
heterologous erythrocytes in irradiated parental strain mice. I. Failure to collaborate with 
B cells of the opposite parental strain not associated with active suppression. J. Exp. Med. 
147:1142. 
30.  Singer, A., K. S. Hathcock, and R. J. Hodes. 1980. Cellular and genetic control of antibody 
responses. VIII. MHC-restrieted recognition of accessory cells, not B cells, by parent-specific 
subpopulations of normal F1 T  helper cells.J. Immunol. 124:1079. 
31.  Andersson, J., M. H. Schreier, and F. Melchers. 1980. T-cell-dependent B-cell stimulation 
is H-2 restricted and antigen dependent only at the resting B-cell level. Proc. Natl. Acad. Sci. 
U. S. A. 77:1612. 